hsa-miR-134

ncRNA information

ncRNA name

hsa-miR-134

Specific or universal ncRNAs

Universal ncRNAs

Class

MicroRNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

MAGI2

Cancer information

Cancer name

Lung Adenocarcinoma

Cancer site

Lung

Treatment information

Treatment type

Chemotherapy

Drug

Gefitinib

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Down

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Whereas knockdown of these miRNAs inhibited the EMT process and reversed TGF-b1-induced resistance to gefitinib.

Tissue resource

lung adenocarcinoma cell lines A549

lung adenocarcinoma cell lines LC2/ad

lung adenocarcinoma cell lines PC3

lung adenocarcinoma cell lines PC9

lung adenocarcinoma cell lines RERF-LCKJ

lung adenocarcinoma cell lines RERF-LCMS

lung adenocarcinoma cell lines PC14

lung adenocarcinoma cell lines ABC-1

lung adenocarcinoma cell lines A549

lung adenocarcinoma cell lines LC2/ad

lung adenocarcinoma cell lines PC3

lung adenocarcinoma cell lines PC9

lung adenocarcinoma cell lines RERF-LCKJ

lung adenocarcinoma cell lines RERF-LCMS

lung adenocarcinoma cell lines PC14

lung adenocarcinoma cell lines ABC-1

lung adenocarcinoma cell lines A549

lung adenocarcinoma cell lines LC2/ad

lung adenocarcinoma cell lines PC3

lung adenocarcinoma cell lines PC9

lung adenocarcinoma cell lines RERF-LCKJ

lung adenocarcinoma cell lines RERF-LCMS

lung adenocarcinoma cell lines PC14

lung adenocarcinoma cell lines ABC-1

Experiment

qRT-PCR,Western blot,Luciferase reporter assay


Institute

RIKEN Cell Bank

Country

Continent